Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Engage Grants Program

Université de Sherbrooke

$25,000.00

Conception et réalisation d'une unité de synthèse automatisée pour la préparation du [18F]-FMPEP-d2.

FY 2019-20

Summary
Inversago Pharma is a biotechnology company specializing in the development of new types of inverse agonists and antagonists of the cannabinoid type 1 (CB1) receptor for the treatment of several metabolic disorders such as diabetes (type II) in a more targeted way and therefore, causing fewer side effects. The company wants to perform efficacy and safety tests on this type of molecule by positron emission tomography (PET) imaging in order to market them, but to do this, Inversago Pharma must first find a way to synthesize a radiotracer for a better validation. For radioprotection reasons, complete automation of radiotracer synthesis is mandatory. A dedicated synthesis unit is also essential to avoid contamination and to reproduce optimal reaction and purification conditions. The research team of Pre Guérin therefore proposes, within the framework of this project, to design and build a synthesis unit or box in which all the stages of the radiotracer synthesis can be performed in an automated way while respecting both the radiation protection standards and the needs of the partner.
Program
Engage Grants Program
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
538082-2019
Name nom
Guérin, Brigitte
Department département
Médecine nucléaire et radiobiologie
Organization id
68
Institution établissement
Université de Sherbrooke
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2019
Competition year année de concours
2019
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
1552
Committee name en
Quebec Internal Decision Committee
Committee name fr
Comité de décision interne pour le Québec
Area of application code
519
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Other manufactured products and processes
Area of application fr
Autres produits et procédés de fabrication
Research subject code
1702
Research subject group en
Design and manufacturing
Research subject group fr
Conception et fabrication
Research subject en
Advanced manufacturing
Research subject fr
Méthodes de fabrication avancées
Installment
inst:1 - 1
Partie
1
Nb partie
1
Application title
Conception et réalisation d'une unité de synthèse automatisée pour la préparation du [18F]-FMPEP-d2.
Keyword
NSERC
Application summary
Inversago Pharma is a biotechnology company specializing in the development of new types of inverse agonists and antagonists of the cannabinoid type 1 (CB1) receptor for the treatment of several metabolic disorders such as diabetes (type II) in a more targeted way and therefore, causing fewer side effects. The company wants to perform efficacy and safety tests on this type of molecule by positron emission tomography (PET) imaging in order to market them, but to do this, Inversago Pharma must first find a way to synthesize a radiotracer for a better validation. For radioprotection reasons, complete automation of radiotracer synthesis is mandatory. A dedicated synthesis unit is also essential to avoid contamination and to reproduce optimal reaction and purification conditions. The research team of Pre Guérin therefore proposes, within the framework of this project, to design and build a synthesis unit or box in which all the stages of the radiotracer synthesis can be performed in an automated way while respecting both the radiation protection standards and the needs of the partner.